• Heron Therapeutics held its annual stockholder meeting on June 11, 2026.
• Shareholders ratified Withum Smith+Brown as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Shareholders authorized an amended and restated 2007 equity incentive plan, increasing shares available for issuance by 16.56 million.
• Shareholders authorized an amendment to the 1997 employee stock purchase plan, increasing shares available for issuance by 10 million.
• Shareholders ratified, on a nonbinding advisory basis, adoption of the Tax Benefits Preservation Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heron Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-272388), on June 16, 2026, and is solely responsible for the information contained therein.